The MTFMT gene helps mitochondria, the parts of cells that make energy, start making some of the proteins they need to work well. If this gene does not work properly, cells may struggle to make enough energy, which can lead to a rare inherited mitochondrial condition. People with harmful variants in the MTFMT gene may have developmental delay, low muscle tone, movement or balance problems, fatigue, seizures, or heart involvement. Symptoms and severity can vary widely from person to person.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or managing activities in the body. Some genes carry the information needed to produce proteins, the working parts of cells. Others mainly regulate when certain processes happen, where they occur, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a more in depth look at this topic, you can learn more in the LearnHub.
Overview
MTFMTGene function
What if the gene works
The MTFMT gene helps mitochondria, your cells' energy makers, start making key proteins. This supports normal energy production, especially in tissues with high energy needs like the brain and muscles.
Risk
What if the gene does not work
Pathogenic variants in the MTFMT gene can cause a mitochondrial condition affecting brain development and movement, sometimes with feeding, breathing, or heart problems. Milder or more severe variants can influence when symptoms begin and how strongly they affect daily life.
Treatment
What does that mean for your treatment
No MTFMT-specific treatment or drug choice is currently established in clinical guidelines for pathogenic variants in the MTFMT gene. Care is usually supportive and guided by a person’s symptoms rather than a gene-directed therapy.
Conditions associated with MTFMT
Gene function
What if the gene works
Your cells need a steady energy supply to power muscles, nerves, and organs. The MTFMT gene helps mitochondria, the parts of cells that make most energy, build a small set of proteins they need. Understanding how the MTFMT gene supports energy production in mitochondria helps make sense of its everyday role in the body.
Inside mitochondria, the MTFMT gene prepares the special starter molecule used to begin making certain proteins. It adds a small chemical tag called a formyl group, which helps the protein-building machinery recognize the correct starting point.
This gene supports the production of proteins made inside mitochondria rather than elsewhere in the cell. Those proteins become part of the energy-making system that helps turn food and oxygen into usable cell energy.
By helping mitochondrial protein synthesis start smoothly, the MTFMT gene supports steady energy production in tissues with high energy needs. This includes organs such as the brain, heart, and muscles, which rely on mitochondria throughout the day.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help create normal human diversity, including variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can more substantially change how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MTFMT gene can make the protein unstable, shorten it, or reduce its ability to carry out the first step in mitochondrial protein production. In practical terms, how MTFMT gene variants affect mitochondrial function depends on how much working protein remains. Milder variants may leave some activity, while more severe variants can greatly disrupt this process, which may contribute to earlier or more pronounced features in MTFMT-related disease.
How variants are linked to conditions
Pathogenic variants in both copies of the MTFMT gene cause a rare inherited condition called combined oxidative phosphorylation deficiency 15, often diagnosed as Leigh syndrome or Leigh syndrome spectrum disease. In practice, MTFMT gene variants linked to Leigh syndrome are associated with developmental delay, low muscle tone, movement problems, and periods of worsening after infections. This is a confirmed genetic diagnosis rather than a common risk finding.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology and are common across the general population. Most do not have a direct effect on health and simply contribute to natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For MTFMT, the main factor is genetics: people usually develop related mitochondrial disease only if they inherit harmful changes in both copies of the gene. There is not broadly confirmed evidence that lifestyle or environmental factors meaningfully change that inherited risk, although symptoms can vary from one person to another.
Inheritance of MTFMT variants
MTFMT-related conditions follow an autosomal recessive inheritance pattern. In practical terms, how MTFMT variants are inherited usually means a child receives one altered copy of the MTFMT gene from each parent. Parents who carry one variant are typically called carriers, and with each pregnancy there is a 25% chance the child will inherit both altered copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither altered copy. This pattern affects sons and daughters equally.
What does my MTFMT result mean for my family?
For families with an MTFMT-related condition, the pattern is usually recessive, which means parents are often healthy carriers and brothers or sisters may also be affected or be carriers. Close relatives may want to learn whether the same gene change is present in the family. Children of someone with an MTFMT-related condition will usually be carriers, and the chance of having an affected child depends on the other biological parent's results.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the MTFMT gene, labs use genetic testing for MTFMT variants on a blood or saliva sample. Most tests read the gene’s DNA sequence, and some also check for missing pieces of DNA. Results can show whether a person carries a variant linked to mitochondrial disease and may help confirm a diagnosis.
When should I consider getting a genetic test?
MTFMT testing may be worth considering when a baby, child, or adult has signs of an inherited condition that affects how cells make energy, such as developmental delay, muscle weakness, movement problems, or repeated episodes of serious illness. It can also be useful if a close family member has an MTFMT variant or a confirmed mitochondrial diagnosis.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they explain varies by the condition and the type of variant involved. Over time, lifestyle, environment, age, and medical history also affect how the body works. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down or move a drug through the body differently, so the same treatment may work better for one person and less well for another. These differences are common and can influence both benefit and side effects. In practice, genetics is one of several factors that shape medication response, along with age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way people respond to medicines. It focuses on gene-drug relationships to explain why the same treatment can affect one person differently than another. For many medications, genes influence both how strongly a drug works and how the body handles it. This information can support more informed, more personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the MTFMT gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to medicines. General health concerns, new symptoms, or questions about side effects or treatment choices are best discussed with your doctor.